drugset
drugset / Trial / NCT04083846

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)

NCT04083846 ↗

Phase 1 Completed 24 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

This study is a randomized, open-label, fed, single dose, crossover study to investigate the pharmacokinetic profiles and safety of high-dose CKD-385 in healthy volunteers under fed conditions.

Timeline

Start
2019-09-06
Primary completion
2019-10-21
Completion
2019-10-25

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-385 Unknown 64 mg Oral
Subject D744 Unknown — Oral

Indications

cardiovascular disorder